Cargando…
Targeted Delivery of Stk25 Antisense Oligonucleotides to Hepatocytes Protects Mice Against Nonalcoholic Fatty Liver Disease
BACKGROUND & AIMS: Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) are emerging as leading causes of liver disease worldwide. Currently, no specific pharmacologic therapy is available for NAFLD/NASH, which has been recognized as one of the major unmet medical nee...
Autores principales: | Cansby, Emmelie, Nuñez-Durán, Esther, Magnusson, Elin, Amrutkar, Manoj, Booten, Sheri L., Kulkarni, Nagaraj M., Svensson, L. Thomas, Borén, Jan, Marschall, Hanns-Ulrich, Aghajan, Mariam, Mahlapuu, Margit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6411916/ https://www.ncbi.nlm.nih.gov/pubmed/30576769 http://dx.doi.org/10.1016/j.jcmgh.2018.12.004 |
Ejemplares similares
-
Serine/threonine protein kinase 25 antisense oligonucleotide treatment reverses glucose intolerance, insulin resistance, and nonalcoholic fatty liver disease in mice
por: Nuñez‐Durán, Esther, et al.
Publicado: (2017) -
Protein kinase STK25 aggravates the severity of non-alcoholic fatty pancreas disease in mice
por: Nuñez-Durán, Esther, et al.
Publicado: (2017) -
STE20‐Type Protein Kinase MST4 Controls NAFLD Progression by Regulating Lipid Droplet Dynamics and Metabolic Stress in Hepatocytes
por: Caputo, Mara, et al.
Publicado: (2021) -
Depletion of protein kinase STK25 ameliorates renal lipotoxicity and protects against diabetic kidney disease
por: Cansby, Emmelie, et al.
Publicado: (2020) -
Antagonizing STK25 Signaling Suppresses the Development of Hepatocellular Carcinoma Through Targeting Metabolic, Inflammatory, and Pro-Oncogenic Pathways
por: Kurhe, Yeshwant, et al.
Publicado: (2021)